0
Applied AI·June 24, 2026·1 min read

Stanford researchers will discuss their agentic 'scientists' that are on course to reshape drug discovery at VB Transform 2026

Share

Agentic “scientist” stacks aimed at drug discovery are a direct attack on the handoff-heavy, siloed workflows that drive 90–95% failure rates today. If you touch pharma or biotech, assume your real competitor in 3–5 years is an integrated wet-lab + simulation + agent platform, not another CRO.